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Oxidative stress is involved in the etiology of several chronic diseases, including cardiovascular disease,
diabetes, cancer, and neurodegenerative disorders. From this perspective, we have evaluated the possible
antioxidant capacities of ﬁve different phthalocyanines (PCs), consisting of four metallophthalocyanines
(MPCs) and one simple phthalocyanine (PC) in order to explore, for the ﬁrst time, the potential antioxi-
dant activities of these compounds. Our results show that all PCs tested in this study have signiﬁcant
antioxidant activity in lipid peroxidation assay, providing protection from sodium nitroprusside -induced
oxidative damage to supernatant from the homogenized liver, brain, e rim of mice. Compared to the non-
induced control, the PCs were generally more efﬁcient in reducing malondialdehyde levels in all assays
on lipid peroxidation induced by sodium nitroprusside; the order of approximate decrease in efﬁciency
was as follows: manganese-PC (better efﬁciency) > copper-PC > iron-PC > zinc-PC > PC (worst efﬁciency).
Furthermore, the copper-PC and manganese-PC compounds exerted a signiﬁcant protective effect in
deoxyribose degradation assays, when employing Fe2+, Fe2+ + H2O2, and H2O2 solutions. In conclusion,
all PCs tested here were shown to be promising compounds for future in vivo investigations, because
of their potential antioxidant activities in vitro.
 2011 Elsevier Ltd.Open access under the Elsevier OA license.1. Introduction
Phthalocyanines (PCs) are macrocyclic complexes whose p sys-
tems (bonds in which the atomic orbitals overlap in parallel, form-
ing an electron density cloud above and below the internuclear
axis) (Graham Solomons and Fryhle, 2001; Pine et al., 1982) are
delocalized over an arrangement of conjugated carbon and nitro-
gen atoms, providing for their unique chemical and physical prop-
erties (Fig. 1) (Leznoff and Lever, 2004; Mckeown, 1998). Due to
the signiﬁcance of the structural component of the p system in
PCs, studies on the nature of the p system and attempts to modu-
late it have been intensively investigated (Day et al., 1975;ophthalocyanines; simple PC,
anine; MnPC, manganese(II)
ron(II) phthalocyanine; SNP,
CT, catalytic therapy; ROS,
reactive substances; DMSO,
rnatant fraction; H2DCF-DA,
cloroindophenol sodium salt
lhydrazyl; TCA, trichloroace-
BSA, bovine serum albumin.
x: +55 55 3220 8978.
r (F.A.A. Soares).
evier OA license.Svetlana et al., 1996). Many of the properties of PCs are highly
dependent on the extent of intermolecular p–p stacking interac-
tions between the planar faces of the macrocycles. PCs as metal
complexes, generated by replacement of the hydrogen atoms in
the central cavity, are usually called metallophthalocyanines
(MPCs), and these central metal ions play a critical role in regulat-
ing the properties of MPCs (Hanack et al., 2001). Thus, since the
structural arrangement of MPCs is determined by the size and loca-
tion of the metal ion center, in relation to the mean plane of the
aromatic PC ligand, several conformations have been described
(Barthel et al., 2002).
PCs and related macrocycles are of great interest due to the
variety of interesting optoelectronic and coordination properties
they display (Beltrán et al., 2004; Leznoff and Lever, 2004;
Mckeown, 1998; Mitzel et al., 2004), and they serve as active com-
ponents in several diverse ﬁelds (Cook and Mater, 1996; Emmelius
et al., 1989). The applicability of these complexes has been inves-
tigated in different areas, especially in materials science (de la Tor-
re et al., 1998; Farren et al., 2002; Loosli et al., 2005; Mizuguchi and
Matsumoto, 1999; Nazeeruddin et al., 1998; Pandey and Herman,
1998; Sies, 1985) and in therapeutic medicine (Pandey and
Herman, 1998); examples include photodynamic therapy (PDT)
and catalytic therapy (CT). They are also emerging modalities for
Fig. 1. The chemical structure of phthalocyanine (PC) (A). The chemical structures
of MPCs [copper(II) phthalocyanine (CuPc), manganese(II) phthalocyanine (man-
ganese-nPc), zinc phthalocyanine (zinc-Pc), iron(II) phthalocyanine (iron-PC) ] were
obtained by replacing X by one of the following metals: Cu2+, Mn2+, Zn2+, and Fe2+,
respectively (B).
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cancer, skin disorders, and macular degeneration. Photodynamic
therapy involves the administration of a photosensitizing drug
(PCs) and its subsequent activation by light to produce reactive
oxygen species and/or free radicals that selectively destroy target
cells (Dougherty et al., 1998; Hasan et al., 2002).
Catalytic therapy (CT) is a cancer treatment modality that em-
ploys a transitionmetal complex as a catalyst and a secondmolecule
as a substrate. Catalytic therapy is similar to photodynamic therapy
(PDT), and is another approach to cancer treatment (Dougherty et al.,
1998). This radiation-based approach for the treatment of solid
malignancies involves the systemic or local administration of a
photosensitizing agent (PCs), followed by irradiationwith an appro-
priatewavelength of visible light. Photodynamic therapyhas proved
to be successful in the treatment of a broad range of diverse solid tu-
mors; however, its use is limited to tissues and areas accessible to
light or light-producing devices (Brown et al., 2004; Juzeniene
et al., 2006; Triesscheijn et al., 2006). In contrast, CT is potentially
a more versatile cancer treatment modality, which, although also
based on the generation of reactive oxygen species (ROS), uses a
combination of substrate molecules and a catalyst in place of light
irradiation (Feofanov et al., 2000). Mechanisms underlying the anti-
tumor actionof CT are similar toX-ray therapy andPDT cancer treat-
ments, in that CT’s actions are dependent on the production of ROS,
which subsequently induces oxidative degradation of critical cellu-
lar molecules and organelles (Fuchs et al., 2000; Heck et al., 2004,
2003; Plaetzer et al., 2005). However, until the present study, there
have not been any studies depicting the possible antioxidant
properties of the PCs.
It is important to consider that biomolecular reactions involving
free radicals, and their relationship with oxidative stress, have been
the subject of a multitude of scientiﬁc investigations, and this re-
search consistently tops the list of current topics in health andmed-
icine (Balentine, 1982; Ji, 1995). Oxidative stress is related to an
imbalance between the production of reactive species and the
strength of the antioxidant defenses, which can result in several
impairments of cell function, culminating in cell death (Grune
et al., 2001; Scott, 1997). It has been suggested that when exacer-
bated, oxidative stress, which is present during normal cell metabo-
lism, is involved in the etiology of several chronic diseases, includingcardiovascular disease, diabetes, cancer, andneurodegenerative dis-
orders (Grune et al., 2001; Scott, 1997). On the other hand, antioxi-
dant intake has emerged as an alternative therapeutic approach for
several pathological conditions related to oxidative damage in the
biological systems responsible for normal cell functions (Scott,
1997; Simic and Karel, 1980).
Antioxidant defenses belong to two major groups: (1) those
preventing the initiation of a peroxidative chain reaction, and (2)
those slowing down the progression of a peroxidative chain reac-
tion (Puntel et al., 2009; Simic and Karel, 1980). Research focused
on the elucidation of the antioxidant and therapeutic properties of
new chemical compounds have been continuously performed by
our research group (de Avila et al., 2006; de Lima Portella et al.,
2008; Puntel et al., 2009). Consistent with this line of research pro-
gress, we have conducted the present studies on the antioxidant
potential of PCs, as well as the elucidation of the mechanisms of ac-
tion of the PCs.
Thus, considering the relevance of oxidative stress in medicine
in general, and the increasing interest in PCs compounds in partic-
ular, our research group is concerned with the elucidation of pos-
sible antioxidant potentials for ﬁve different PCs. To elucidate
their potential use as antioxidant compounds, we have performed
the present in vitro study which analyzed four MPCs and one PC.2. Materials and methods
2.1. Drugs
Oxidant agents including hydrogen peroxide, and FeSO4 were
obtained from local suppliers. PCs [29H, 31-phthalocyanine (PC),
copper(II) phthalocyanine (copper-PC), manganese(II) phthalocya-
nine (manganese-PC), zinc phthalocyanine (zinc-PC), iron(II) phtha-
locyanine (iron-PC)], sodium nitroprusside (SNP), the purity of each
compound is respectively 98%, 97%, 90%,P90%, 90% and 99–102%,
and other reagents were supplied by Sigma–Aldrich Chemical.
2.2. Animals
Untreated 40 adult male Swiss albino mice 50–60 days old,
weighing 25–35 g, were used. These mice were obtained from
our own breeding colony. The animals were maintained in an air
conditioned room (20–25 C) under a 12 h light/dark cycle, and
with water and food provided ad libitum. All experimental proce-
dures were conducted according to guidelines of the Committee of
Care and Use of Experimental Animal Research of the Federal
University of Santa Maria, Brazil.
2.3. Assays with tissue homogenates
2.3.1. Tissue preparation
Mice were sacriﬁced by cervical dislocation, and the liver, kid-
neys, and brain were quickly removed, placed on ice, and homog-
enized in 10 volumes of cold, Tris buffer (10 mM, pH 7.4). The
homogenates were centrifuged at 4000g at 4 C for 10 min to
yield a low-speed supernatant fraction (S1) for each tissue (liver,
kidney and brain) that was used for SNP-induced lipid peroxida-
tion and H2DCF-DA assays.
2.3.2. SNP-induced lipid peroxidation assay
The antioxidant effect of the PCs was evaluated against produc-
tion of SNP (5 lM)-induced thiobarbituric acid reactive substances
(TBARS), using vehicle, dimethyl sulfoxide (DMSO), or PCs
(1–100 lM). The S1 was pre-incubated for 1 h at 37 C in a buffered
medium with the PCs in the presence or absence of SNP. TBARS
formation was determined spectrophotometrically at 532 nm,
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et al. (1979). In this work we used the SNP as a mechanism of tox-
icity, in a concentration of 5 lM according to previously described
(Puntel et al., 2009). In fact, sodium nitroprusside (SNP) is a good
chemical inducer of lipid peroxidation in mice tissues (Rauhala
et al., 1998), since it release in a short-lasting time NO in tissue
preparations.
2.3.3. Not-induced lipid peroxidation assay
The antioxidant effect of the PCs was evaluated against basal
production of thiobarbituric acid reactive substances (TBARS), using
vehicle, dimethyl sulfoxide (DMSO), or PCs (1–100 lM). The S1 was
pre-incubated for 1 h at 37 C in a buffered medium with the PCs.
TBARS formation was determined spectrophotometrically at
532 nm, using malondialdehyde (MDA) as a standard, according to
Ohkawa et al. (1979).
2.3.4. H2DCF-DA assay
S1 was used for the 2,7-dichlorodihydroﬂuorescein diacetate
(H2DCF-DA) oxidation assay to evaluate levels of RS (reactive spe-
cies). S1, in Tris buffer (10 mM, pH 7.4) was incubated with differ-
ent PCs at concentrations of 1, 5, 10, 50, and 100 lM at 37 C. After
1 h, aliquots were removed, H2DCF-DA (7 lM) was added to the
medium, and incubation was continued for 1 h in the dark. Fluores-
cence was determined using 488 nm for excitation and 520 nm for
emission. A standard curve was created using increasing concen-
trations of 2,6-dicloroindophenol sodium salt hydrate (DCF) incu-
bated in parallel (Pérez-Severiano et al., 2004). The results were
analyzed as a percentage value in relation to the control group.
2.3.5. Protein determination
The protein content was determined according to Lowry et al.
(1951), using bovine serum albumin (BSA) as a standard.
2.4. Assays without tissue homogenates
2.4.1. Nitric oxide (NO) scavenging assay
The scavenging of NOwas assessed by incubating SNP (5 mM, in
potassium buffer) with different PC concentrations at 25 C. After
120 min, 0.5 mL of incubation solution was sampled and mixed
with 0.5 mL of Griess reagent (Green et al., 1981), and the absor-Fig. 2. Effect of PC (phthalocyanine), cooper-PC (copper(II) phthalocyanine), manganese
(zinc phthalocyanine) on the SNP (sodium nitroprusside)-induced lipid peroxidation a
36.6 nmol MDA/mg protein (C). ap < 0.05, bp < 0.01, cp < 0.001, compared to control indu
⁄p < 0.01, §p < 0.001, compared to control not induced by Student–Newman–Keuls test fbance was measured at 550 nm. The amount of nitrite was calcu-
lated using different concentrations of sodium nitrite. A curve of
sodium nitrite, constructed in the presence of the PCs in order to
verify interaction with nitrite, depicted no interference of PCs with
the color development after addition of Griess reagent. The values
were compared to a control to determine the percentage of inhibi-
tion of nitrite reaction with Griess reagent, depicted by the PCs, as
an index of the NO scavenging activity (Marcocci et al., 1994).2.4.2. DPPH radical scavenging activity assay
Themeasurement of a PC’s scavenging activity against the radical
(DPPH)wasperformed in accordancewithChoi et al. (2002). Brieﬂy,
85 lMDPPH was added to a medium containing different PCs con-
centrations. Themediumwas incubated for 30 min at room temper-
ature, and the decrease in absorbancemeasured at 518 nmdepicted
the scavenging activity of the PCs against DPPH (Puntel et al., 2009).
The values are expressed as percentage of inhibition of DPPH absor-
bance in relation to the control values without the PCs.2.4.3. Deoxyribose degradation assay
The deoxyribose degradation assay was performed according to
Puntel et al. (2005). Brieﬂy, the reaction medium was prepared
containing the following reagents at the ﬁnal concentrations indi-
cated: PCs (concentrations indicated in the ﬁgures), deoxyribose
(3 mM) ethanol (5%), potassium phosphate buffer (0.05 mM, pH
7.4), FeSO4 (50 lM), and H2O2 (500 lM). Solutions of FeSO4 and
H2O2 were made prior to use. Reaction mixtures were incubated
at 37 C for 30 min and stopped by the addition of 0.8 mL of tri-
chloroacetic acid (TCA) 2.8%, followed by the addition of 0.4 mL
of thiobarbituric acid (TBA) 0.6%. Next, the medium was incubated
at 100 C for 20 min and the absorbance was recorded at 532 nm
(Gutteridge, 1981; Halliwell and Gutteridge, 1981). Standard
curves of MDA were made for each experiment to determine the
MDA generated by the deoxyribose degradation. The values are ex-
pressed as a percentage of control values (without PCs).2.5. Statistical analysis
Statistical signiﬁcance was assessed by one-way ANOVA,
followed by the Student–Newman–Keuls test for post-hoc-PC (manganese(II) phthalocyanine), iron-PC (iron(II) phthalocyanine), and zinc-PC
ssay, in S1 from mouse liver. Values are expressed as % of control not induced,
ced (—) by SNP (5 lM). Data are presented as the mean ± S.E.M. (n = 3). #p < 0.05,
or post-hoc comparison.
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tically signiﬁcant at values of p < 0.05, p < 0.01 and p < 0.001.
3. Results
3.1. The chemical structures of PCs
The chemical structure of a PC is shown in Fig. 1A. The chemical
structures of MPCs (copper-PC, manganese-PC, zinc-PC, and iron-
PC) were obtained by replacing X with one of the following metals:
Cu2+, Mn2+, Zn2+, or Fe2+, respectively (Fig. 1B).Fig. 3. Effect of PC (phthalocyanine), cooper-PC (copper (II) phthalocyanine), manganese
(zinc phthalocyanine) on the SNP (sodium nitroprusside)-induced lipid peroxidation a
36.6 nmol MDA/mg protein. ap < 0.05, bp < 0.01, cp < 0.001, compared to control induc
⁄p < 0.01, §p < 0.001, compared to control not induced by Student–Newman–Keuls for p
Fig. 4. Effect of PC (phthalocyanine), cooper-PC (copper(II) phthalocyanine), manganese
(zinc phthalocyanine) on the SNP (sodium nitroprusside)-induced lipid peroxidation a
36.6 nmol MDA/mg protein. ap < 0.05, bp < 0.01, cp < 0.001, compared to control induc
⁄p < 0.01, §p < 0.001, compared to control not induced by Student–Newman–Keuls test f3.2. SNP-induced lipid peroxidation assay
The PC signiﬁcantly decreased the SNP-induced lipid peroxida-
tion in liver, kidney, and brain tissues of mice at concentrations
ranging from 1 to 100 lM (Figs. 2–4, respectively).
Similarly, cooper-PC (Figs. 2–4), and manganese-PC (Figs. 2–4)
signiﬁcantly decreased SNP-induced lipid peroxidation in liver,
kidney, and brain at all tested concentrations (1–100 lM). More-
over, the manganese-PC was able to decrease the lipid peroxida-
tion to levels lower than those of the controls, both in liver, and
brain tissues (Figs. 2 and 4, respectively).-PC (manganese(II) phthalocyanine), iron-PC (iron(II) phthalocyanine), and zinc-PC
ssay, in S1 from mouse kidney. Values are expressed as % of control not induced,
ed (—) by SNP (5 lM). Data are presented as the mean ± S.E.M. (n = 3). #p < 0.05,
ost-hoc comparison.
-PC (manganese(II) phthalocyanine), iron-PC (iron(II) phthalocyanine), and zinc-PC
ssay, in S1 from mouse brain. Values are expressed as % of control not induced,
ed (—) by SNP (5 lM). Data are presented as the mean ± S.E.M. (n = 3). #p < 0.05,
or post-hoc comparison.
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cantly decreased the SNP-induced lipid peroxidation in liver, kid-
ney, and brain tissues of mice (Figs. 2–4, respectively) to the
control levels. However, in kidney, the iron-PC at 50 and 100 lM,
was not able to achieve the control levels.
The zinc-PC, at all tested concentrations, signiﬁcantly decreased
the SNP-induced lipid peroxidation in liver, kidney, and brain tis-
sues of mice (Figs. 2–4 respectively) to the control levels. However,
in kidney, the zinc-PC was less effective.2+
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Fig. 5. Effect of manganese-Pc (manganese(II) phthalocyanine) on deoxyribose
degradation assay. Values are expressed as % of control not induced, 0.94 lM/g
deoxyribose (—). ⁄p < 0.001, compared to control induced by Fe2+ 50 lM (A), H2O2
500 lM (B), and Fe2+ 50 lM plus H2O2 500 lM (C). Data are presented as the
mean ± S.E.M. (n = 3). #p < 0.001, compared to control not induced by Student–
Newman–Keuls test for post-hoc comparison.In the liver, manganese-PC and copper-PC induced lipid perox-
idation levels that were signiﬁcantly lower than that of PC at con-
centrations of 1, 5, 10, 50, and 100 lM (Fig. 2). Iron-PC and zinc-PC
in the liver demonstrated no signiﬁcant difference compared to PC
at all concentrations used in this study (Fig. 2). In the liver, manga-
nese-PC demonstrated reduction of SNP-induced lipid peroxida-
tion levels that was lower than that of iron-PC at concentrations
of 1, 5, 10, 50, and 100 lM (Fig. 2).
In addition, manganese-PC decreased the levels of lipid peroxi-
dation in the liver at concentrations of 5, 10, 50, and 100 lM as2+
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Fig. 6. Effect of cooper-Pc (copper(II) phthalocyanine) on deoxyribose degradation
assay. Values are expressed as % of control not induced, 0.94 lM/g deoxyribose (—).
⁄p < 0.001, compared to control induced by Fe2+ 50 lM (A), H2O2 500 lM (B), and
Fe2+ 50 lM plus H2O2 500 lM (C). Data are presented as the mean ± S.E.M. (n = 3).
#p < 0.001, compared to control not induced by Student–Newman–Keuls test for
post-hoc comparison.
Fig. 8. Effect of manganese-PC (manganese(II) phthalocyanine) on the not-induced
lipid peroxidation assay, in S1 from mouse brain. Values are expressed as % of
control (—), 36.6 nmol MDA/mg protein. Data are presented as the mean ± S.E.M.
(n = 3). ⁄p < 0.01, compared to control by Student–Newman–Keuls test for post-hoc
comparison.
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levels of lipid peroxidation in the liver at concentrations of 5, 10,
50, and 100 lM than iron-PC did (Fig. 2). In addition, copper-PC in-
duced lower levels of lipid peroxidation in the liver at concentra-
tions of 50 and 100 lM than zinc-PC did. There was no signiﬁcant
difference between copper-PC and manganese-PC in the liver at
the concentrations used in this study (Fig. 2). At a concentration of
5 lM, iron-PC induced lipid peroxidation levels that were lower
than that of zinc-PC (Fig. 2, p < 0.05).
In the kidney, PC increased levels of lipid peroxidation at
concentrations of 1, 5, 10, 50, and 100 lM as compared to that of
manganese-PC (Fig. 3). PC also increased levels of lipid peroxida-
tion in the kidney at concentrations of 1 and 5 lM as compared
to that of iron-PC, and demonstrated no difference compared to
that of zinc-PC (Fig. 3, p < 0.05).
There was no signiﬁcant difference between copper-PC and
manganese-PC in the kidney at the concentrations used in this
study (Fig. 3). In the kidney, copper-PC effected lower levels of lipid
peroxidation than iron-PC did at concentrations of 50 and 100 lM
(Fig. 3, p < 0.05).
In addition, copper-PC induced lower levels of lipid peroxidation
in the kidney at concentrations of 10, 50, and 100 lM than zinc-PC
did (Fig. 3). Manganese-PC induced no signiﬁcant difference in the
kidney in relation to that of iron-PC and zinc-PC (Fig. 3). There was
no difference between iron-PC and zinc-PC (Fig. 3, p < 0.05).
In the brain, PC induced higher levels of lipid peroxidation com-
pared to that of copper-PC and manganese-PC. There was no signif-
icant difference between PC compared to iron-PC and zinc-PC
(Fig. 4, p < 0.05).
In the brain, manganese-PC effected lower levels of lipid perox-
idation than zinc-PC did at concentrations of 5, 10, 50, and 100 lM,
and at 10 lM compared to that of copper-PC (Fig. 4). Iron-PC re-
sulted in no signiﬁcant difference in the brain in relation to man-
ganese-PC, zinc-PC, and copper-PC (Fig. 4). Compared to zinc-PC,
copper-PC induced lower levels of lipid peroxidation in the brain
at concentrations of 1, 50, and 100 lM (Fig. 4, p < 0.05).3.3. Not-induced lipid peroxidation assay
Themanganese-PC (Figs. 7 and 8) signiﬁcantly decreased the ba-
sal lipid peroxidation in liver and brain at all tested concentrations
(1–100 lM). Moreover, the manganese-PC was able to decrease theFig. 7. Effect of manganese-PC (manganese(II) phthalocyanine) on the not-induced
lipid peroxidation assay, in S1 from mouse liver. Values are expressed as % of
control (—), 36.6 nmol MDA/mg protein. Data are presented as the mean ± S.E.M.
(n = 3). ⁄p < 0.01, §p < 0.001, compared to control by Student–Newman–Keuls test
for post-hoc comparison.lipid peroxidation to levels lower than those of the controls, both in
liver, and brain tissues (Figs. 7 and 8, respectively).
The PC, copper-PC, Zinc-PC, and iron-PC did not show any anti-
oxidant effects in basal-lipid peroxidation (data not shown).
3.4. H2DCF-DA, nitric oxide (NO) scavenging and DPPH radical
scavenging activity assays
The PC and MPCs did not show any antioxidant effects in tests
involving H2DCF-DA, nitric oxide (NO) scavenging and DPPH rad-
ical scavenging activities (data not shown).
3.5. Deoxyribose degradation assay
We evaluated the effect of manganese-PC and cooper-PC in the
assay for degradation of deoxyribose, because these two com-
pounds showed better results when tested in SNP-induced lipid
peroxidation, compared to PC, zinc-PC, and iron-PC.
The manganese-PC (1–50 lM) signiﬁcantly decreased the deoxy-
ribose degradation induced by H2O2 (Fig. 5B), however it was less
able to reduce the Fe-induced deoxyribose degradation (Fig. 5A).
Additionally, the manganese-PC effect against Fe2+ + H2O2-induced
deoxyribose degradation (Fig. 5C)was at the samemagnitude as seen
for Fe2+ alone, indicating that manganese-PC interferes with H2O2
without affecting Fe2+ chemistry.
In contrast, the copper-PC (1–50 lM) signiﬁcantly decreased
the deoxyribose degradation induced by Fe2+ or H2O2 alone, how-
ever, it showed no additional protective effect in the Fenton reac-
tion (Fe2+ + H2O2) (Figs. 6A–C, respectively).
4. Discussion
In the current study, our research group investigated and clari-
ﬁed the antioxidant properties of four different MPCs and a PC, be-
cause of the relevance of these compounds in the contexts of
oxidative stress, disease etiology, and for the progress of medicine
(Balentine, 1982; Ji, 1995). The experiments performed in this
study revealed a signiﬁcant antioxidant capacity of PCs against li-
pid peroxidation induced by SNP in all tested tissues (Figs. 2–4).
Results from the present study showed more signiﬁcant antioxi-
dant effects in trials using cooper-PC and manganese-PC (Figs. 2–
4, respectively). Additionally, lipid peroxidation assays revealed
that iron-PC and zinc-PC have less signiﬁcant antioxidant effects
in kidney samples (Fig. 3, respectively) compared with samples
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some chemical change should have occurred in the extruded iron-
PC and zinc-PC complexes, due to biological metabolism of the
kidney enzymes, by mechanisms not yet known.
On the other hand, the PC and the MPCs did not prevent RS for-
mation, as indicated by the H2DCF-DA assay, at all concentrations
tested (data not shown). This particular assay corresponds to a
nonspeciﬁc assay, where generated RS oxidizes H2DCF-DA, result-
ing in the generation of a ﬂuorescent sub-product (Pérez-Severiano
et al., 2004), whose production was not prevented by the presence
of a PC, or by the presence of the various MPCs employed in the
study. Nevertheless, manganese-PC and cooper-PC showed antiox-
idant effects in the deoxyribose degradation assay (Figs. 5 and 6,
respectively), thereby justifying the continuation of this study after
the antioxidant results against lipid peroxidation induced by SNP
were determined (Figs. 2–4).
Similar to the ﬁndings in the SNP-induced lipid peroxidation,
manganese-PC and cooper-PC decreased oxidative stress induced
by solutions of Fe2+, H2O2, and Fe2+ + H2O2 in the deoxyribose deg-
radation assay (Fig. 5A–C, and Fig. 6A–C, respectively). However,
manganese-PC did not show antioxidant effects as expressive as
those found in SNP-induced lipid peroxidation (Figs. 2–4), although
it had a signiﬁcant antioxidant effect in the deoxyribose degrada-
tion assay (Fig. 5). We believe that further studies are necessary
to understand this matter.
In addition, the PC and the MPCs had no effect in the DPPH and
nitric oxide (NO) radical scavenging activity assays, (data not
shown), which excludes the possibility that these PC compounds
possess scavenging activity against the biologically relevant radi-
cals, NO and DPPH. Thus, we suggest that the PC and the MPCs
may be acting by avoiding the generation of free radicals, or block-
ing the oxidative action of free radicals against the lipids present in
the cells from biological samples, or against the deoxyribose moi-
ety. Furthermore, these PCs compounds can act by directly degrad-
ing hydroperoxides such as H2O2, which is a common mechanism
used by antioxidants (Scott, 1997; Simic and Karel, 1980).
We believe that the mechanism of action of the PC and the
MPCs is deeply related to resonance that occurs in the p system lo-
cated in these structures (Leznoff and Lever, 2004; Mckeown,
1998) (Fig. 1A and B). The p systems in these compounds corre-
spond to bonds in which atomic orbitals overlap in parallel, com-
prising an electron density cloud above and below the
internuclear axis, for example, as in the 2p orbital of nitrogen
and d orbital of metal, called a pp–dp bond (Lee, 1999).
Thus, due to the fact that the cooper-PC and the manganese-PC
showed better antioxidant effects against lipid peroxidation in-
duced by SNP (Figs. 2–4) compared to the PC, the iron-PC and
the zinc-PC (Figs. 2–4, respectively), we hypothesize here that
the relative effects found are due to a total resonance around the
ring, resulting in a twist of the coordination of the metal center,
thus making a bridge between the opposite sides of the structure
in the MPCs. Moreover, the difference in results of one metal com-
plex compared to another, must be a consequence of a better res-
onance with Cu2+ and Mn2+ in comparison to Fe2+ and Zn2+ present
in the other MPC structures (Barthel et al., 2002; Day et al., 1975;
Hanack et al., 2001; Leznoff and Lever, 2004; Mckeown, 1998;
Svetlana et al., 1996).
Manganese-PC displayed a signiﬁcant antioxidant effect per se
to reduce the basal levels of lipid peroxidation in the liver and
brain, which conﬁrms the results of the SNP-lipid peroxidation as-
say. We can deduce that manganese-PC not only reversed the SNP-
induced lipid peroxidation but also act to prevent possible oxida-
tive stress because it was able to decrease the basal levels of oxida-
tive stress (Figs. 7 and 8, respectively).
Comparative analysis of manganese-PC and copper-PC in the li-
ver demonstrated a statistically similar effect in preventing lipidperoxidation induced by SNP (Fig. 2). On the other hand, manga-
nese-PC and copper-PC demonstrated better antioxidant activity
than copper-PC, zinc-PC, and PC did in the liver, indicating that
manganese-PC and copper-PC possess a better antioxidant mecha-
nism for the prevention of SNP-induced lipid peroxidation (Fig. 2).
Copper-PC and zinc-PC in the liver presented very similar re-
sults and were superior to PC; together with the results of the
other PC compounds, they support the existence of an antioxidant
mechanism strongly reliant on the presence of metals in PC struc-
ture (Fig. 2).
Manganese-PC demonstrated an antioxidant activity similar to
that of copper-PC, iron-PC, and zinc-PC in the liver (Fig. 3). On
the other hand, copper-PC presented an antioxidant activity, pre-
vention of lipid peroxidation, higher than that detected with the
other PCs (Fig. 3). This indicates that the structure of copper PCs
plays a key role in the reversal of renal cell lipid peroxidation
(Fig. 3).
Copper-PC in the brain demonstrated a better antioxidant effect
than PC and zinc-PC did in preventing SNP-induced lipid peroxida-
tion (Fig. 4). In addition, manganese-PC in the brain yielded better
results than zinc-PC did in the prevention of lipid peroxidation
(Fig. 4). Other comparisons between PCs in the brain presented
similar results, demonstrating that copper-PC and manganese-PC
effected better antioxidant activities in brain structures than other
PCs did, which is probably related to the presence of copper and
manganese in the structure of the PCs (Fig. 4).5. Conclusion
In conclusion, we believe that the PC and MPCs tested in this
investigation deserve further attention as to their probable impor-
tance as antioxidants, especially due to the results obtained in as-
says of lipid peroxidation induced by SNP, lipid peroxidation not-
induced and also due to the results of the deoxyribose degradation
assay. In addition, our research group believes that cooper-PC and
manganese-PC have promising antioxidant potentials, as evi-
denced by the positive effects observed in comparison to the other
metal complexes tested in our assays.6. Conﬂict of interest statement
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